Breast cancer: Clinical practice guidelines in oncology

Robert W. Carlson; Benjamin O. Anderson; Harold J. Burstein; Charles E. Cox; Stephen B. Edge; William B. Farrar; Lori J. Goldstein; William J. Gradishar; Daniel F. Hayes; Clifford Hudis; Mohammad Jahanzeb; Britt Marie Ljung; Lawrence B. Marks; Beryl McCormick; Lisle M. Nabell; Lori J. Pierce; Elizabeth C. Reed; Samuel M. Silver; Mary Lou Smith; George Somlo; Richard L. Theriault; John H. Ward; Eric P. Winer; Antonio C. Wolff

doi:10.6004/jnccn.2005.0015

Breast cancer: Clinical practice guidelines in oncology

Robert W. Carlson, Benjamin O. Anderson, Harold J. Burstein, Charles E. Cox, Stephen B. Edge, William B. Farrar, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford Hudis, Mohammad Jahanzeb, Britt Marie Ljung, Lawrence B. Marks, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Elizabeth C. Reed, Samuel M. Silver, Mary Lou Smith, George SomloRichard L. Theriault, John H. Ward, Eric P. Winer, Antonio C. Wolff

School of Medicine

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment, but also to contribute to improving the treatment of future patients.

Original language	English (US)
Pages (from-to)	238-289
Number of pages	52
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	3
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2005.0015
State	Published - May 2005

Keywords

Adjuvant therapy
Breast cancer
Breast-conserving therapy
Chemotherapy
Ductal carcinoma in situ
Endocrine therapy
Lobular carcinoma in situ
Mastectomy
NCCN Clinical Practice Guidelines
Radiation therapy

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2005.0015

Cite this

Carlson, R. W., Anderson, B. O., Burstein, H. J., Cox, C. E., Edge, S. B., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., Hayes, D. F., Hudis, C., Jahanzeb, M., Ljung, B. M., Marks, L. B., McCormick, B., Nabell, L. M., Pierce, L. J., Reed, E. C., Silver, S. M., Smith, M. L., ... Wolff, A. C. (2005). Breast cancer: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 3(3), 238-289. https://doi.org/10.6004/jnccn.2005.0015

Carlson, RW, Anderson, BO, Burstein, HJ, Cox, CE, Edge, SB, Farrar, WB, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, C, Jahanzeb, M, Ljung, BM, Marks, LB, McCormick, B, Nabell, LM, Pierce, LJ, Reed, EC, Silver, SM, Smith, ML, Somlo, G, Theriault, RL, Ward, JH, Winer, EP & Wolff, AC 2005, 'Breast cancer: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 3, no. 3, pp. 238-289. https://doi.org/10.6004/jnccn.2005.0015

@article{a51f5297d0fb42ac8f5972001a54bbca,

title = "Breast cancer: Clinical practice guidelines in oncology",

abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment, but also to contribute to improving the treatment of future patients.",

keywords = "Adjuvant therapy, Breast cancer, Breast-conserving therapy, Chemotherapy, Ductal carcinoma in situ, Endocrine therapy, Lobular carcinoma in situ, Mastectomy, NCCN Clinical Practice Guidelines, Radiation therapy",

author = "Carlson, {Robert W.} and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Cox, {Charles E.} and Edge, {Stephen B.} and Farrar, {William B.} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Clifford Hudis and Mohammad Jahanzeb and Ljung, {Britt Marie} and Marks, {Lawrence B.} and Beryl McCormick and Nabell, {Lisle M.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Silver, {Samuel M.} and Smith, {Mary Lou} and George Somlo and Theriault, {Richard L.} and Ward, {John H.} and Winer, {Eric P.} and Wolff, {Antonio C.}",

year = "2005",

month = may,

doi = "10.6004/jnccn.2005.0015",

language = "English (US)",

volume = "3",

pages = "238--289",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - Breast cancer

T2 - Clinical practice guidelines in oncology

AU - Carlson, Robert W.

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Cox, Charles E.

AU - Edge, Stephen B.

AU - Farrar, William B.

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford

AU - Jahanzeb, Mohammad

AU - Ljung, Britt Marie

AU - Marks, Lawrence B.

AU - McCormick, Beryl

AU - Nabell, Lisle M.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Silver, Samuel M.

AU - Smith, Mary Lou

AU - Somlo, George

AU - Theriault, Richard L.

AU - Ward, John H.

AU - Winer, Eric P.

AU - Wolff, Antonio C.

PY - 2005/5

Y1 - 2005/5

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment, but also to contribute to improving the treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment, but also to contribute to improving the treatment of future patients.

KW - Adjuvant therapy

KW - Breast cancer

KW - Breast-conserving therapy

KW - Chemotherapy

KW - Ductal carcinoma in situ

KW - Endocrine therapy

KW - Lobular carcinoma in situ

KW - Mastectomy

KW - NCCN Clinical Practice Guidelines

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=24944459075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944459075&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2005.0015

DO - 10.6004/jnccn.2005.0015

M3 - Review article

C2 - 16002000

AN - SCOPUS:24944459075

SN - 1540-1405

VL - 3

SP - 238

EP - 289

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Breast cancer: Clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this